BioLife Solutions Inc. (NASDAQ: BLFS) kicked off on May 22, 2023, at the price of $21.40, up 3.88% from the previous trading day. During the day, the shares moved up to $22.445 and dropped to $21.17 before settling in for the closing price of $21.40. Over the past 52 weeks, BLFS has traded in a range of $11.81-$26.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 71.10% over the last five years. While this was happening, its average annual earnings per share was recorded 74.80%. With a float of $39.78 million, this company’s outstanding shares have now reached $43.03 million.
The firm has a total of 466 workers. Let’s measure their productivity. In terms of profitability, gross margin is +27.28, operating margin of -24.67, and the pretax margin is -89.53.
BioLife Solutions Inc. (BLFS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of BioLife Solutions Inc. is 2.50%, while institutional ownership is 94.00%. The most recent insider transaction that took place on May 18, was worth 652,692. In this transaction 10% Owner of this company bought 30,000 shares at a rate of $21.76, taking the stock ownership to the 75,027 shares. Before that another transaction happened on May 17, when Company’s 10% Owner bought 30,027 for $21.30, making the entire transaction worth $639,446. This insider now owns 45,027 shares in total.
BioLife Solutions Inc. (BLFS) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 3/30/2023, the organization reported -$0.32 earnings per share (EPS), lower than consensus estimate (set at -$0.21) by -$0.11. This company achieved a net margin of -86.43 while generating a return on equity of -33.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.80% per share during the next fiscal year.
BioLife Solutions Inc. (NASDAQ: BLFS) Trading Performance Indicators
Take a look at BioLife Solutions Inc.’s (BLFS) current performance indicators. Last quarter, stock had a quick ratio of 1.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.44, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of BioLife Solutions Inc. (BLFS)
Analysing the last 5-days average volume posted by the [BioLife Solutions Inc., BLFS], we can find that recorded value of 0.45 million was better than the volume posted last year of 0.31 million. As of the previous 9 days, the stock’s Stochastic %D was 79.21%. Additionally, its Average True Range was 1.35.
During the past 100 days, BioLife Solutions Inc.’s (BLFS) raw stochastic average was set at 56.08%, which indicates a significant decrease from 77.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.50% in the past 14 days, which was lower than the 66.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.97, while its 200-day Moving Average is $21.62. Now, the first resistance to watch is $22.73. This is followed by the second major resistance level at $23.22. The third major resistance level sits at $24.00. If the price goes on to break the first support level at $21.45, it is likely to go to the next support level at $20.67. Now, if the price goes above the second support level, the third support stands at $20.18.
BioLife Solutions Inc. (NASDAQ: BLFS) Key Stats
The company with the Market Capitalisation of 981.90 million has total of 43,456K Shares Outstanding. Its annual sales at the moment are 161,760 K in contrast with the sum of -139,810 K annual income. Company’s last quarter sales were recorded 37,700 K and last quarter income was -13,710 K.
